Brunei Health Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Brunei Health Wire.

Press releases published on June 11, 2026

Jun. 11, 2026

InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures

Indeterminate GlobeNewswire

Jun. 11, 2026

FLYTE EXPANDS STRATEGIC RELATIONSHIP WITH VOLATO BY JOINING VAUNT PLATFORM

Indeterminate GlobeNewswire

Jun. 11, 2026

ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress 

Indeterminate GlobeNewswire

Jun. 11, 2026

Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research

Indeterminate GlobeNewswire

Jun. 11, 2026

Loma Linda University Health and Nudj Health Launch Integrated Whole-Person Primary Care Model Designed to Advance the Future of Healthcare Delivery

Indeterminate GlobeNewswire

Jun. 11, 2026

Tris Pharma to Present on Dual NOP/MOP Receptor Agonist in Pain Management and Substance Use Disorder at the College on Problems of Drug Dependence (CPDD) 88th Annual Scientific Meeting, 2026

Indeterminate GlobeNewswire

Jun. 11, 2026

Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer

Indeterminate GlobeNewswire

Jun. 11, 2026

Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference

Indeterminate GlobeNewswire

Jun. 11, 2026

Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program

Indeterminate GlobeNewswire

Jun. 11, 2026

Spinach® is the Number One Vape Brand in Canada

Indeterminate GlobeNewswire

Jun. 11, 2026

Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026

Indeterminate GlobeNewswire

Jun. 11, 2026

AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease

Indeterminate GlobeNewswire

Jun. 11, 2026

Clinical Data Showed Average 67% Pain Score Reduction and 50% Gain in Walking Distance with Cartigenix HP® in 90 Days*†

Indeterminate GlobeNewswire

Jun. 11, 2026

What Science-Backed Subscription Health Programs Measure Differently

Indeterminate GlobeNewswire

Jun. 11, 2026

Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program

Indeterminate GlobeNewswire

Jun. 11, 2026

Neion Bio Raises Oversubscribed $23 Million Series A to Advance Biologics Manufacturing Platform and Expand Pipeline

Indeterminate GlobeNewswire

Jun. 11, 2026

BrewDog Rolls Back Pint Prices to £2 Across Scotland for 72-Hour Bank Holiday Weekend, Celebrating the National Team’s Return

Indeterminate GlobeNewswire

Jun. 11, 2026

C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population

Indeterminate GlobeNewswire

Jun. 11, 2026

Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026

Indeterminate GlobeNewswire

Jun. 11, 2026

Verano Completes 1-for-5 Reverse Stock Split, Advancing the Company’s Path Towards Prospective U.S. Stock Exchange Listing

Indeterminate GlobeNewswire